Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Bifunctional Mesoporous Zirconium Phosphonates For Delivery Of Nucleic Acids.

Yan Tang, Yubao Ren, X. Shi
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The bifunctional mesoporous zirconium phosphonates (ZrBFs) were synthesized through surfactant-assisted co-condensation of ZrCl(4) with two different phosphonic acids, both 1-phosphomethylproline (H(3)PMP) and 1,4-bis(phosphomethyl)piperazine (BPMP), in a one-pot procedure. The L-proline group of H(3)PMP and piperazine group of BPMP in the frameworks endow ZrBFs with pH-controllable release function and high cell penetration capability, which was derived from the reversible protonation-deprotonation of L-proline groups and piperazine groups on the mesoporous walls under different pH values (pH sensitivity) as well as further functionalization with biological modifiers via the carboxyls in L-proline groups on the outer surface (functionalizability), respectively. ZrBFs, possessing cationic frameworks once formed, exhibit high payload for salmon sperm DNA as model nucleic acid owing to strong electrostatic attraction between them. On the basis of pH-sensitive ZrBFs carriers and assisted by lag-time films coating, the time- and pH-controlled oral colon-targeted nucleic acid delivery systems have been developed, which can carry most of the loaded salmon sperm DNA to the colon under dual control, time control and pH value control. Furthermore, salmon sperm DNA can remain intact during delivery, as evidenced by the fact that the released salmon sperm DNA in the pH transition release experiment still retain its structural integrity and native conformation. Also, fluorescence spectra demonstrate that ZrBFs can be further functionalized with a cell-penetrating peptide of octaarginine (R8) via the carboxyls in L-proline groups of H(3)PMP on the outer surface using a coupling agent, which will enhance the penetration capability of ZrBFs through biomembranes. ZrBFs have a potential application as a new kind of carrier in oral delivery of nucleic acids targeting the colon for gene therapy of colon-related diseases due to their unique bifunctionality.
This paper references
10.1002/CHEM.200304764
Comparison of micro- and mesoporous inorganic materials in the uptake and release of the drug model fluorescein and its analogues.
K. A. Fisher (2003)
Methods Find
M. E. K. Kraeling (1992)
10.1136/gut.27.8.886
Transit of pharmaceutical dosage forms through the small intestine.
S. Davis (1986)
10.1039/B707626F
pH-Controllable drug release using hydrogel encapsulated mesoporous silica.
S-W Song (2007)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1021/CM990764H
Characterization of MCM-48 Silicas with Tailored Pore Sizes Synthesized via a Highly Efficient Procedure
M. Kruk (2000)
10.1016/J.JCONREL.2006.05.006
Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.
Qunli Tang (2006)
10.1039/B616746B
Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.
R. Mellaerts (2007)
10.1021/CM048988+
S+I- ionic formation mechanism to new mesoporous aluminum phosphonates and diphosphonates
J. Haskouri (2004)
10.1039/B212266A
Hydrothermal synthesis and crystal structure of two Co phosphonates containing trifunctional phosphonate anions: Co3(O3PCH2NH2CH2PO3)2 and Co3(O3PCH2-NC4H7-CO2)2·5H2O
A. Turner (2003)
10.1021/JA02242A004
THE ADSORPTION OF GASES ON PLANE SURFACES OF GLASS, MICA AND PLATINUM.
I. Langmuir (1918)
Development of a colonic release capsule dosage form and the absorption of insulin.
M. Kraeling (1992)
10.1016/S0378-5173(02)00458-1
Stability aspects of salmon calcitonin entrapped in poly(ether-ester) sustained release systems.
R. van Dijkhuizen-Radersma (2002)
10.1016/S0169-409X(98)00075-1
Oral insulin delivery.
Carino (1999)
10.1016/S0958-1669(00)00202-0
Emerging protein delivery methods.
J. Cleland (2001)
10.1093/NAR/6.9.3093
Interaction of DNA with a porphyrin ligand: evidence for intercalation.
R. Fiel (1979)
10.1021/CM0101069
Gas adsorption characterization of ordered organic-inorganic nanocomposite materials
M. Kruk (2001)
10.1016/J.MICROMESO.2011.07.023
Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: Sensitive response to the narrow pH range
Fang Chen (2012)
10.1039/C0JM04490C
pH-controllable release using functionalized mesoporous silica nanoparticles as an oral drug delivery system
Shih-Hsun Cheng (2011)
10.1246/CL.2002.1036
Mesoporous Zirconium Phosphate-phenylphosphonate and Its Functionalization
N. Ren (2002)
10.1021/CM0011559
A New Property of MCM-41: Drug Delivery System
M. Vallet-Regí (2001)
10.1021/CM0344966
Synthesis of novel mesoporous aluminum organophosphonate by using organically bridged diphosphonic acid
T. Kimura (2003)
10.1515/zpch-1907-5723
Über die Adsorption in Lösungen
H. Freundlich (1907)
10.1039/B612637E
Synthesis of ordered mesoporous aluminium alkylenediphosphonates with integrated inorganic–organic hybrid frameworks
T. Kimura (2007)
10.1016/J.JCONREL.2004.03.005
Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery.
A. Doadrio (2004)
10.1016/0168-3659(94)90026-4
The influence of biodegradable microcapsule formulations on the controlled release of a protein
H. Sah (1994)
10.1021/CM0490672
Synthesis of Mesostructured and Mesoporous Aluminum Organophosphonates Prepared by Using Diphosphonic Acids with Alkylene Groups
T. Kimura (2005)
10.1136/GUT.10.10.842
A new method for studying gut transit times using radioopaque markers
J. M. Hinton (1969)
10.1080/10717540701606244
Silica-Based Mesoporous Materials as Drug Delivery System for Methotrexate Release
Ida Stefania Carino (2007)
10.1039/C0JM01442G
Periodic mesoporous titanium phosphonate hybrid materials
T. Ma (2010)
10.1039/B820534E
Fabrication of smart nanocontainers with a mesoporous core and a pH-responsive shell for controlled uptake and release
Chun-Yan Hong (2009)
Microporous Mesoporous Mater
Zhu (2011)
10.1002/ADFM.200800521
Synthesis and Characterization of Positive-Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti-Inflammatory Drug?
Chia-Hung Lee (2008)
10.1039/C0JM00587H
pH-Sensitive mesoporous zirconium diphosphonates for controllable colon-targeted delivery
X. Shi (2010)
Microporous Mesoporous Mater
Y. H. Yue (2002)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1016/J.MICROMESO.2006.10.015
Simple removal of oligomeric surfactants and triblock copolymers from mesostructured precursors of ordered mesoporous aluminum organophosphonates
T. Kimura (2007)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1016/S0168-3659(97)00204-6
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
10.1002/EJIC.200501084
Mesoporous Aluminium Organophosphonates Functionalized with ChiralL‐Proline Groups in the Pore
Xin Shi (2006)
10.1016/0003-2697(72)90102-9
2-Aminophenanthroimidazole, fluorescent product of the reaction of phenanthrenequinone with arginine.
H. Itano (1972)
10.1039/c2cs15308d
Functionalized mesoporous silica materials for controlled drug delivery.
P. Yang (2012)
10.1039/B517710C
Cationic phosphorus-carbon-pnictogen cages isolobal to [C5R5]+.
C. Fish (2006)
10.1021/LA051167E
Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
S-W Song (2005)
10.1016/0378-5173(83)90089-3
Monitoring antacid preparations in the stomach using gamma scintigraphy
J. Jenkins (1983)
10.1021/CM981061N
Adsorption of taxol into ordered mesoporous silicas with various pore diameters
H. Hata (1999)
10.1039/B510101H
Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern
J. Doadrio (2006)
10.1021/JP9043978
pH-Responsive Drug Release from Polymer-Coated Mesoporous Silica Spheres
Q. Gao (2009)
10.1039/B922651F
New developments in ordered mesoporous materials for drug delivery
M. Manzano (2010)
10.1039/b920964f
Functionalized periodic mesoporous titanium phosphonate monoliths with large ion exchange capacity.
T. Ma (2010)
10.1021/JA002481S
Mesoporous titanium phosphate molecular sieves with ion-exchange capacity.
A. Bhaumik (2001)
10.1016/0306-3623(91)90440-H
Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules.
G. Gwinup (1991)
10.1002/EJIC.200400071
The First Pure Mesoporous Aluminium Phosphonates and Diphosphonates − New Hybrid Porous Materials
J. Haskouri (2004)
10.1016/S0169-409X(97)00051-3
Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development.
Jones (1997)
10.1021/CM0401490
Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices
J. Andersson (2004)
10.1248/CPB.26.337
Reaction of Guanidines with α-Diketones. V. Mechanism of the Fluorescence Reaction of Monosubstituted Guanidines with 9,10-Phenanthraquinone
S. Tanabe (1978)
10.1016/J.SOLIDSTATESCIENCES.2010.12.039
Construction of a novel pH-sensitive drug release system from mesoporous silica tablets coated with Eudragit
Yingpu Xu (2011)
10.1021/IC700892Z
Pore-size tunable mesoporous zirconium organophosphonates with chiral L-proline for enzyme adsorption.
Xin Shi (2007)
10.1016/S0378-5173(03)00158-3
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
10.1021/CM050919N
Oligomeric Surfactant and Triblock Copolymer Syntheses of Aluminum Organophosphonates with Ordered Mesoporous Structures
T. Kimura (2005)
10.1021/JO01343A067
The Direct Synthesis of α-Aminomethylphosphonic Acids. Mannich-Type Reactions with Orthophosphorous Acid
Kurt Moedritzer (1966)
Systemic delivery of peptides and proteins across absorptive mucosae.
A. Sayani (1996)
10.1016/J.MATERRESBULL.2008.07.001
Ph-Controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate
Wujun Xu (2009)
10.1038/81359
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
J. Rothbard (2000)
10.1016/0039-9140(92)80252-9
Spectrofluorimetric determination of guanethidine sulphate, guanoxan sulphate and amiloride hydrochloride in tablets and in biological fluids using 9,10-phenanthraquinone.
M. H. Abdel-Hay (1992)



This paper is referenced by
10.1021/acsomega.6b00437
Synthesis of Calcium Bisphosphonate/Calcium Polyacrylate Spheres for Gene Delivery
XiaoNa Wei (2017)
10.1002/AOC.5017
Rapid Suzuki‐Miyaura cross‐coupling reaction catalyzed by zirconium carboxyphosphonate supported mixed valent Pd(0)/Pd(II) catalyst
B. Bhattacharyya (2019)
10.1016/J.MCAT.2017.12.013
CsxH3-xPW12O40 nanoparticles dispersed in the porous network of Zr-pillared α-zirconium phosphate as efficient heterogeneous catalyst for synthesis of spirooxindoles
S. Pradhan (2018)
10.1002/EJOC.201301673
Synthesis of Zirconium Phosphonate Supported L‐Proline as an Effective Organocatalyst for Direct Asymmetric Aldol Addition
M. Angeloni (2014)
10.1002/cctc.201501303
Organic–Inorganic Hybrid Metal Phosphonates as Recyclable Heterogeneous Catalysts
P. Bhanja (2016)
10.1007/978-3-662-45634-7_5
Modification and Potential Applications of Organic–Inorganic Non-Siliceous Hybrid Materials
Yun-Pei Zhu (2015)
10.1021/ACS.IECR.6B00208
Soft Template Assisted Synthesis of Zirconium Resorcinol Phosphate Nanocomposite Material for the Uptake of Heavy-Metal Ions
Arshid Bashir (2016)
10.1016/j.jinorgbio.2013.09.009
Metal-polybenzimidazole complexes as a nonviral gene carrier: effects of the DNA affinity on gene delivery.
Xueying Huang (2013)
10.3390/ma13235366
Advances and Challenges in the Creation of Porous Metal Phosphonates
Bharadwaj Mysore Ramesha (2020)
10.1002/advs.201500363
Yolk–Shell‐Structured Aluminum Phenylphosphonate Microspheres with Anionic Core and Cationic Shell
Liqiu Zhang (2016)
10.1039/C6RA17353E
Polyaniline–polystyrene membrane for simple and efficient retrieval of double-stranded DNA from aqueous media
W. Q. Brandão (2016)
10.1007/s10934-019-00816-9
Preparation and catalytic application of sulfonated polyvinyl alcohol-Al-pillared α-zirconium phosphate (SPV-AZP) hybrid material towards synthesis of 4,6-diarylpyrimidin-2(1H)-ones
D. Majhi (2019)
10.1039/C5CY00107B
Insights into mesoporous metal phosphonate hybrid materials for catalysis
Yun-Pei Zhu (2015)
10.1016/J.MATDES.2018.05.041
Zirconium phosphate (ZrP)-based functional materials: Synthesis, properties and applications
H. Xiao (2018)
10.1016/j.msec.2014.12.079
Mesoporous materials as multifunctional tools in biosciences: principles and applications.
M. Moritz (2015)
10.1039/C4QI00011K
Metal phosphonate hybrid materials: from densely layered to hierarchically nanoporous structures
Yun-Pei Zhu (2014)
10.1007/978-3-662-45634-7
Mesoporous Organic-Inorganic Non-Siliceous Hybrid Materials: Basic Principles and Promising Multifunctionality
Yun-Pei Zhu (2015)
10.1021/JP411346K
Mesoporous Zirconium Phenylphosphonates for Selective Enrichment of Phosphopeptides
Xiaona Wei (2014)
10.1016/B978-0-323-47720-8.00024-9
Mesoporous materials and technologies for development of oral medicine
S. Shen (2017)
10.1007/s10934-019-00741-x
Sulfamic acid well dispersed in the micropores of Al-pillared α-ZrP as efficient heterogeneous catalyst for synthesis of structurally diverse 1,4-dihydropyridines under mild conditions
D. Majhi (2019)
Semantic Scholar Logo Some data provided by SemanticScholar